Stratasys Blog
Cardiovascular Systems, Inc., based in St. Paul, Minnesota, is a medical device company focused on developing and commercializing innovative solutions for treating peripheral and coronary artery disease (PAD and CAD). The company’s Orbital Atherectomy Systems treat calcified plaque in arterial vessels throughout the leg and heart in a few minutes of treatment time, and address many of the limitations associated with existing surgical, catheter and pharmacological treatment alternatives. To help fight the battle against CAD and PAD, CSI works continuously to advance their devices and develop new innovations. CSI’s innovative drive has expanded their utilization of 3D printing across all facet…

How 3D Printing Can Enhance and Expand Medtech Opportunities

In the September 7, 2017 issue of Medtech Insight, Scott Rader, founder and leader of the Healthcare Solutions team at Stratasys, along with Clemens Moeller and Christophe Durand of the Boston Consulting Group, explores the benefits of 3D-printed devices and h…

We’re Kicking Off the 2018 Extreme Redesign Challenge Today

Are you a design or engineering student who has a unique idea and an interest in 3D printing?   Do you have an innovative solution that will surely impact the world for the greater good that needs a venue for discovery? Our 14th annual Extreme Redesign challen…